Suchergebnisse - "Perez, Alessandro"

PubPharm (41)

1

Clinical relevance of exosome-derived microRNAs in Ovarian Cancer : Looking for new tumor biological fingerprints

enthalten in: Critical reviews in oncology/hematology | 2024

von Fanale, D. | Corsini, L. | Bono, M. | +18

2

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs) : Results From a Multi-Institutional Cohort Study

enthalten in: The oncologist | 2024

von Incorvaia, L. | De Biase, D. | Nannini, M. | +22

3

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

4

Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer : Making the invisible visible

enthalten in: Critical reviews in oncology/hematology | 2023

von Gristina, V. | La Mantia, M. | Peri, M. | +15

5

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab

enthalten in: Frontiers in oncology | 2023

von Incorvaia, L. | Dimino, A. | Algeri, L. | +21

6

Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab : finding the missing links in the symbiotic immune-metabolic interplay

enthalten in: Therapeutic advances in medical oncology | 2023

von Incorvaia, L. | Rinaldi, G. | Badalamenti, G. | +17

7

Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors

enthalten in: Cancers | 2022

von Dimino, A. | Brando, C. | Algeri, L. | +17

8

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC) : A Real-World Prospective Study

enthalten in: Cancers | 2022

von Gristina, V. | Barraco, N. | La Mantia, M. | +15

9

BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome : Looking for the hidden meaning

enthalten in: Critical reviews in oncology/hematology | 2022

von Fanale, D. | Pivetti, A. | Cancelliere, D. | +13

10

Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

enthalten in: Critical reviews in oncology/hematology | 2022

von Fanale, D. | Corsini, L. | Scalia, R. | +15

1
2
3
4
5
Nächster »
[5]